Disclaimer: Note that these slides are not legally binding and do not represent any commitment on
behalf of the European Commission
An Enlarging Europe
• Now 25 countries
with population of
460 million
• Enlargement to 27
due in 2007 (Bulgaria
and Romania)
• EU reseach includes
Israel, Turkey and
Switzerland among
others...
Problem Solving Potential
• Development of new and useful products across a
wide range of sectors – address needs of citizens
Curve
introductions
Biotechnology
• Protein replacement
therapies for humans Large pharmaceuticals
• R&D productivity decreased
by 25% since 1990
Nanotechnology
• Nano-materials
• Nano-electronics
• Nano-health, etc.
Source: McKinsey
Time
Making the Transition
Private
Knowledge
Funding
Public
6000
Europe
5000 USA
Japan
Others
FP6
4000
(EU)
NNI
3000 (USA)
2000
1000
0
1997 1998 1999 2000 2001 2002 2003 2004
0,00
100,00
200,00
300,00
400,00
EC
G
373
er
m
an
y
293
Fr
an
N ce
et
he
U
224
ni rla
te nd
d s
A K
124
ss
oc gd
ia om
te
d
100
St
at
es
B
67
el
gi
um
60
Ita
ly
60
Ire
la
nd
33
Sw
ed
en
15
Fi
nl
an
d
15
A
us
tr
ia
13
Sp
ai
n
D
13
en
m
ar
k
9
G
re
ec
e
1
EU Public Funding in 2004
Overall Funding in 2004
Other
Europe Others
Asia North 27% 28%
America
Japan
Europe USA 18%
27%
3,000
Private
Expenditure ( M$ )
1300 Private
1700
2,000
Private
1400
Member
States + States
Associated 400
1,000
1339
Federal Public
991 900
EC Public
477 480
0
Europe US Japan Others
Source: European Commission (2005) : Private figures based upon Lux Research
R&D Areas of Funding
5.0
% "nano*" articles
Rest of World
3.0
2.0
1.0
0.0
1991
1992
1993
1994
1995
1996
1997
1998
1999
2000
2001
2002
2003
2004
Year
UK
Sw itzerland
6%
4%
Europe
US 29%
55% others
5%
Germany
11%
NMP
IST NMP 57%
27% 58% IST
27%
2004 2005
EU Integrated Project
“Cell Programming
by Nanoscaled Devices”
Specific challenges: Objectives
- to turn “macro” medical devices
- to develop an automated
into nano-tools
device for the imprinting of
- to take individual care of every
cells via nanoscaled
single cell injected into the
macromolecular landscapes,
system
the NanoScapes
Total costs: 26.05 m Euro - to non-invasively produce
well-defined populations of
EU funding: 17.6 m Euro individually programmed cells
Duration: 48 months
Start date: 1st March 2004
Partners: 36
EU Network of Excellence
“Nanoscale Quantum Simulations for
Nanostructures and Advanced Materials”
Duration: 48 months
Start date: 1st July 2004
End date: 31st June 2008
NANOQUANTA
Linking National
Programmes
• MNT ERA-NET started as a core group in January
2004, joining 8 support programmes with micro-
and nanotechnology foci from all over Europe.
• In January 2005, the MNT ERA-NET extended to 21
participating programmes in 17 European
countries
• Nanoscience ERA-NET also starting this year...
Infrastructure: Capacities
• Launched by the CEA and brings together 3,500
people on a integrated campus: R&D, innovation,
education...
• Nanoforum survey of EU infrastructure and
networks is almost finished (www.nanoforum.org)
Europe’s integrated and
responsible approach
• Communication Towards a European Strategy for
Nanotechnology adopted 12 May 2004
Societal
Issues
Infrastructure
Health, safety,
International Research environmental
Cooperation and and consumer
Development protection
Industrial
Innovation Human
Resources
Good Response to the
Proposed Strategy
• Discussed in the European
Council and conclusions
adopted on 24 September
• Open consultation with 750
responses from a wide range
of stakeholders
• Opinion by Economic and
Social Committee on 15
November 2004
• Action Plan is now being
finalised and is about to be
published....
Health and Environment
• Up to now, six dedicated R&D projects have been
launched at European level
• Total of Euro 10 million € (8 million € in 2005 alone)
and with calls for proposals currently open
Communicating nano
The Commission funds projects
for communicating ethical, legal
and social aspects (ELSA) of
research in nanotechnology to the
public.
Cooperation––Collaborative
Cooperation Collaborativeresearch
research
Ideas––Frontier
Ideas FrontierResearch
Research
People––Human
People HumanPotential
Potential
Capacities––Research
Capacities ResearchCapacity
Capacity
+
JRC(non-nuclear,
JRC (non-nuclear,nuclear)
nuclear)and
andEuratom
Euratom
FP7 budget
(EUR billion, 2004
constant prices)
Euratom
4,193
JRC
1,617
Cooperation
Capacities
39,134
6,594
People
6,279
Ideas
10,447
Cooperation – 9 Themes
1. Health
2. Food, agriculture and biotechnology
3. Information and communication technologies
4. Nanosciences, nanotechnologies, materials
and new production technologies (€4.2
billion)
5. Energy
6. Environment (including climate change)
7. Transport (including aeronautics)
8. Socio-economic sciences and the humanities
9. Security and space
International Cooperation
• Building upon the experience in FP6, aim to boost
cooperation between the EU and advanced Third
Countries (e.g. USA, Japan) in basic research
• Pool knowledge on issues of global interest such
as education, health, environment, metrology,
norms – also ensuring a level playing field
• Define an international “code of good conduct” for
the responsible development of nanotechnology –
key point for consumer and investor confidence
• Provide access to knowledge to economically less
developed countries to contribute towards the
prevention of any “knowledge apartheid”
Thank you for your attention!
Further information on EU programmes:
http://www.cordis.lu/nanotechnology
General information from: